Advertisement

Topics

Celsion nets $6.1mm in registered direct offering

15:40 EDT 30 Oct 2017 | Elsevier Business Intelligence

Celsion Corp. (heat-activated liposomal therapies for cancer) netted $6.1mm in a registered direct offering of 2.64mm common ...

Original Article: Celsion nets $6.1mm in registered direct offering

NEXT ARTICLE

More From BioPortfolio on "Celsion nets $6.1mm in registered direct offering"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...